Skip to main content
Top
Published in: Rheumatology International 11/2013

01-11-2013 | Short Communication

Complicated brucellar spondylodiscitis: experience from an endemic area

Authors: Aysegul Ulu-Kilic, Merve Sefa Sayar, Ediz Tütüncü, Figen Sezen, Irfan Sencan

Published in: Rheumatology International | Issue 11/2013

Login to get access

Abstract

The demographical, clinical, and therapeutical features of patients with brucellar spondylodiscitis (BS) were evaluated in this study. Of the 96 patients with brucellosis, 20 (20.8 %) were diagnosed with spondylodiscitis. Patients who had BS were more likely to be older (p = 0.001), have higher erythrocyte sedimentation rates (p = 0.01), and more likely to be anemic (p = 0.017). Lumbar segment (18/20) was frequently involved region. BS was complicated with paravertebral or epidural abscess in seven, radiculitis in six, and psoas abscess in five of cases. Antibiotic regimens including two or three antibiotics with combination of doxycycline, rifampin, and streptomycin were used. In this series, the mean duration of antimicrobial therapy was 18 weeks (range 12–56 weeks). Attention is drawn to this disease given the need for prolonged duration of treatment especially in complicated cases in order to avoid possible sequelae.
Literature
1.
go back to reference Calik S, Gokengin D (2011) Human brucellosis in Turkey: a review of the literature between 1990 and 2009. Turk J Med Sci 41:549–555 Calik S, Gokengin D (2011) Human brucellosis in Turkey: a review of the literature between 1990 and 2009. Turk J Med Sci 41:549–555
2.
go back to reference Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7:173–182CrossRef Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7:173–182CrossRef
3.
go back to reference Erdem H, Ulu A, Kilic S, Karahocagil M, Sheeta G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, Mert G, Tekin-Koruk S, Dizbay M, Inal AS, Nayman-Alpat S, Bosilkovski M, Inan D, Saltoglu N, Abdel-Baky L, Adeva-Bartolome MT, Ceylan B, Sacar S, Turhan V, Yilmaz E, Elaldi N, Kocak-Tufan Z, Ugurlu K, Dokuzoguz B, Yilmaz H, Gundes S, Guner R, Ozgunes N, Ulcay A, Unal S, Dayan S, Gorenek L, Karakas A, Tasova Y, Usluer G, Bayindir Y, Kurtaran B, Sipahi OR, Leblebicioglu H (2012) The efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 56:1523–1528PubMedCrossRef Erdem H, Ulu A, Kilic S, Karahocagil M, Sheeta G, Eren-Tulek N, Yetkin F, Celen MK, Ceran N, Gul HC, Mert G, Tekin-Koruk S, Dizbay M, Inal AS, Nayman-Alpat S, Bosilkovski M, Inan D, Saltoglu N, Abdel-Baky L, Adeva-Bartolome MT, Ceylan B, Sacar S, Turhan V, Yilmaz E, Elaldi N, Kocak-Tufan Z, Ugurlu K, Dokuzoguz B, Yilmaz H, Gundes S, Guner R, Ozgunes N, Ulcay A, Unal S, Dayan S, Gorenek L, Karakas A, Tasova Y, Usluer G, Bayindir Y, Kurtaran B, Sipahi OR, Leblebicioglu H (2012) The efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 56:1523–1528PubMedCrossRef
4.
go back to reference Gul HC, Erdem H, Bek S (2009) Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 13:e339–e343PubMedCrossRef Gul HC, Erdem H, Bek S (2009) Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 13:e339–e343PubMedCrossRef
5.
6.
go back to reference Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14:e469–e478PubMedCrossRef Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14:e469–e478PubMedCrossRef
7.
go back to reference Abdi-Liae Z, Soudbakhsh A, Jafari S, Tomaj K (2007) Haematological manifestations of brucellosis. Acta Med Iran 45:145–148 Abdi-Liae Z, Soudbakhsh A, Jafari S, Tomaj K (2007) Haematological manifestations of brucellosis. Acta Med Iran 45:145–148
8.
go back to reference Turgut M, Turgut AT, Kosar U (2006) Spinal brucellosis: Turkish experience based on 452 cases published during the last century. Acta Neurochir (Wien) 148:1033–1044 discussion 44CrossRef Turgut M, Turgut AT, Kosar U (2006) Spinal brucellosis: Turkish experience based on 452 cases published during the last century. Acta Neurochir (Wien) 148:1033–1044 discussion 44CrossRef
9.
go back to reference Celik AK, Aypak A, Aypak C (2011) Comparative analysis of tuberculous and brucellar spondylodiscitis. Trop Doct 41:172–174PubMedCrossRef Celik AK, Aypak A, Aypak C (2011) Comparative analysis of tuberculous and brucellar spondylodiscitis. Trop Doct 41:172–174PubMedCrossRef
10.
go back to reference Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G (2007) Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4:e317PubMedCrossRef Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G (2007) Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4:e317PubMedCrossRef
11.
go back to reference Colmenero JD, Ruiz-Mesa JD, Plata A, Bermudez P, Martin-Rico P, Queipo-Ortuno MI, Reguera JM (2008) Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis 46:426–433PubMedCrossRef Colmenero JD, Ruiz-Mesa JD, Plata A, Bermudez P, Martin-Rico P, Queipo-Ortuno MI, Reguera JM (2008) Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin Infect Dis 46:426–433PubMedCrossRef
12.
go back to reference Pappas G, Seitaridis S, Akritidis N, Tsianos E (2004) Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen. Int J Antimicrob Agents 24:502–507PubMedCrossRef Pappas G, Seitaridis S, Akritidis N, Tsianos E (2004) Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen. Int J Antimicrob Agents 24:502–507PubMedCrossRef
13.
go back to reference Alp E, Doganay M (2008) Current therapeutic strategy in spinal brucellosis. Int J Infect Dis 12:573–577PubMedCrossRef Alp E, Doganay M (2008) Current therapeutic strategy in spinal brucellosis. Int J Infect Dis 12:573–577PubMedCrossRef
Metadata
Title
Complicated brucellar spondylodiscitis: experience from an endemic area
Authors
Aysegul Ulu-Kilic
Merve Sefa Sayar
Ediz Tütüncü
Figen Sezen
Irfan Sencan
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2555-5

Other articles of this Issue 11/2013

Rheumatology International 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.